ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control and adding savory flavors are ways that ...

For example, just under two in five of current users report drinking less alcohol and dining out less since starting a GLP-1 ...

MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight ...

Dozens of studies suggest GLP-1 agonists may also cut the risk of ... One issue with the analysis is that the team didn’t report the actual number of people affected by each condition, making ...

Share on Pinterest GLP-1 drugs may improve brain and heart health but could cause problems for the kidneys and pancreas, according to a new study. FreshSplash/Getty Images Researchers report that ...

Eggs are lean protein and appeal to people taking Ozempic, Wegovy, or other GLP-1 medications. But a big spike in prices has ...

Recent polling suggests that approximately 1 in 8 U.S. adults report having ever used a GLP-1 medication. As demand for GLP-1 medications remains steadfast, this survey asked PCPs, who had more ...

Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

Compared to another common class of kidney medications, called DPP4is, GLP1-RA medications did better in helping slow the progression of kidney disease, keeping kidney disease patients out of the ...

GLP-1 Receptor Agonist Market is estimated to be valued at USD 25.10 Bn in 2024 and is expected to reach USD 55.70 Bn by 2031, exhibiting a CAGR of 12.1%. BURLINGAME, CA, UNITED STATES, February 4 ...

Are you a print subscriber? Activate your account. By Tim Nudd - 14 min 58 sec ago 2 hours 35 min ago By Parker Herren - 2 hours 48 min ago By Brian Bonilla - 2 hours 48 min ago By Jean-Paul ...